CTXR: the balance sheet

MyFinsight

For the year ending 2025-09-30, CTXR has $130,938,025 in assets. $53,410,425 in debts. $4,252,290 in cash and cash equivalents.

Unit: Dollar

Balance Sheets	2025-09-30
Cash and cash equivalents	4,252,290
Inventory	22,286,693
Prepaid expenses	1,395,490
Total current assets	27,934,473
Operating lease right-of-use asset, net	818,694
Deposits	38,062
In-process research and development	92,800,000
Goodwill	9,346,796
Total other assets	102,184,858
Total assets	130,938,025

Accounts payable	13,693,692
License payable	22,650,000
Accrued expenses	4,190,253
Accrued compensation	3,292,447
Note payable	1,000,000
Operating lease liability	88,348
Total current liabilities	44,914,740
Deferred tax liability	7,770,760
Operating lease liability non current	724,925
Total liabilities	53,410,425
Common stock - 0.001 par value 250,000,000 and 16,000,000 shares authorized at september 30, 2025 and 2024, respectively 18,067,744 and 7,247,243 shares issued and outstanding at september 30, 2025 and 2024, respectively	18,068
Additional paid-in capital	306,336,239
Accumulated deficit	-238,804,129
Total citius pharmaceuticals, inc. stockholders equity	67,550,178
Non-controlling interest	9,977,422
Total equity	77,527,600
Total liabilities and equity	130,938,025